Drug Approval | July 22, 2024
Rusan Pharma’s API plant in Ankleshwar receives USFDA GMP approval
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The facility is a part of Lupin Manufacturing Solutions
The Unit has been issued GMP Certification from ANVISA-Brazil
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
Laurus Labs receives EIR from USFDA for API facilities
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Renews GMP certifications for India and Malaysia sites
_256_384.jpg)
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
